AEGiS-UPI: New cellular target for HIV drugs proposed United Press InternationalImportant note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




New cellular target for HIV drugs proposed

United Press International - May 28, 2009


U.S. scientists say human immunodeficiency virus drug developers should focus on immune cells called macrophages instead of traditionally targeted T cells.

In the largest study of its kind, researchers from the University of Florida and five other institutions said they discovered that in diseased cells, such as cancer cells, that are also infected with HIV, nearly all the virus was packed into macrophages, whose job is to "eat" invading disease agents. The researchers said they also found that up to half of the macrophages were hybrids, formed when pieces of genetic material from several parent HIV viruses combined to form new strains.

Such "recombination," they said, is responsible for formation of mutants that easily elude immune system surveillance and escape from anti-HIV drugs.

"Macrophages are these little factories producing new hybrid particles of the virus, making the virus probably even more aggressive over time," Assistant Professor and study co-author Marco Salemi said. "If we want to eradicate HIV we need to find a way to actually target the virus specifically infecting the macrophages."

The findings were reported in a recent issue of the online journal PLoS One.
090528
UP090517


Copyright © 2009 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .